European Venous Registry

NCT ID: NCT06906250

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-05

Study Completion Date

2034-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The European Venous Registry (EVeR) is an international repository of data on the treatments and outcomes of people with deep venous disease. The registry is designed to evaluate the outcomes of venous interventions over a ten-year period, with the ultimate goal to inform clinical decision making through the delivery of scientific evidence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Venous Disease of the Lower Limbs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

all patients suffering from deep venous disease of the lower limbs

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with an imaging-confirmed new diagnosis of acute or chronic lower limb deep venous disease involving the iliac and/or common femoral veins, with or without extension to the inferior vena cava, or patients with an imaging-confirmed new diagnosis involving the IVC only.
* Consent to enter registry.

Exclusion Criteria

* Unable to consent to enter into registry.
* Isolated upper limb DVT.
* Central venous thrombosis (e.g. superior vena cava obstruction).
* Isolated deep vein thrombosis below the common femoral vein.
* Isolated superficial venous thrombosis.
* Isolated superficial venous thrombophlebitis.
* Isolated varicose veins.
* Aged \<18 years.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Baccellieri Domenico

Prof., M.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Vascular Surgery

Marseille, France, France

Site Status RECRUITING

European Venous Center

Aachen, Germany, Germany

Site Status RECRUITING

Clinic of Vascular and Endovascular Surgery at Athens Medical Group

Athens, Greece, Greece

Site Status RECRUITING

Interventional Radiology, Galway University Hospitals

Galway, Ireland, Ireland

Site Status RECRUITING

IRCCS San Raffaele Hospital

Milan, Italy, Italy

Site Status RECRUITING

Department of Vascular and Endovascular Surgery, Erasmus Medical Centre

Rotterdam, Netherlands, Netherlands

Site Status RECRUITING

Vascular and Endovascular Department, Viamed Hospitals

Madrid, Spain, Spain

Site Status RECRUITING

Department of Cardiovascular Surgery, Acibadem University School of Medicine,

Istanbul, Turkey, Turkey (Türkiye)

Site Status RECRUITING

North Bristol NHS Trust

Bristol, United Kingdom, United Kingdom

Site Status RECRUITING

St Thomas' Hospital

London, United Kingdom, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France Germany Greece Ireland Italy Netherlands Spain Turkey (Türkiye) United Kingdom

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Olivier Hartung

Role: primary

Houman Jalaie

Role: primary

Makis Avgerinos

Role: primary

Gerry O'Sullivan

Role: primary

Domenico Baccellieri

Role: primary

0226437377

Marie Josee Van Rijn

Role: primary

Marta Ramirez Ortega

Role: primary

Mert Dumantepe

Role: primary

Baris Ozdemir

Role: primary

Steve Black

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EVeR- European Venous Registry

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bern Venous Stent Registry
NCT02433054 COMPLETED
EVLA and Optimal Timing of Sclerotherapy
NCT04774939 NOT_YET_RECRUITING NA
Venclose digiRF System Post Market Study
NCT05504070 ENROLLING_BY_INVITATION NA